Exact Mass: 232.1271

Exact Mass Matches: 232.1271

Found 162 metabolites which its exact mass value is equals to given mass value 232.1271, within given mass tolerance error 0.01 dalton. Try search metabolite list with more accurate mass tolerance error 0.001 dalton.

Melatonin

N-[2-(5-methoxy-1H-indol-3-yl)ethyl]acetamide

C13H16N2O2 (232.1212)


Melatonin is a member of the class of acetamides that is acetamide in which one of the hydrogens attached to the nitrogen atom is replaced by a 2-(5-methoxy-1H-indol-3-yl)ethyl group. It is a hormone secreted by the pineal gland in humans. It has a role as a hormone, an anticonvulsant, an immunological adjuvant, a radical scavenger, a central nervous system depressant, a human metabolite, a mouse metabolite and a geroprotector. It is a member of acetamides and a member of tryptamines. It is functionally related to a tryptamine. Melatonin is a biogenic amine that is found in animals, plants and microbes. Aaron B. Lerner of Yale University is credited for naming the hormone and for defining its chemical structure in 1958. In mammals, melatonin is produced by the pineal gland. The pineal gland is small endocrine gland, about the size of a rice grain and shaped like a pine cone (hence the name), that is located in the center of the brain (rostro-dorsal to the superior colliculus) but outside the blood-brain barrier. The secretion of melatonin increases in darkness and decreases during exposure to light, thereby regulating the circadian rhythms of several biological functions, including the sleep-wake cycle. In particular, melatonin regulates the sleep-wake cycle by chemically causing drowsiness and lowering the body temperature. Melatonin is also implicated in the regulation of mood, learning and memory, immune activity, dreaming, fertility and reproduction. Melatonin is also an effective antioxidant. Most of the actions of melatonin are mediated through the binding and activation of melatonin receptors. Individuals with autism spectrum disorders (ASD) may have lower than normal levels of melatonin. A 2008 study found that unaffected parents of individuals with ASD also have lower melatonin levels, and that the deficits were associated with low activity of the ASMT gene, which encodes the last enzyme of melatonin synthesis. Reduced melatonin production has also been proposed as a likely factor in the significantly higher cancer rates in night workers. Melatonin is a hormone produced by the pineal gland that has multiple effects including somnolence, and is believed to play a role in regulation of the sleep-wake cycle. Melatonin is available over-the-counter and is reported to have beneficial effects on wellbeing and sleep. Melatonin has not been implicated in causing serum enzyme elevations or clinically apparent liver injury. Melatonin is a natural product found in Mesocricetus auratus, Ophiopogon japonicus, and other organisms with data available. Therapeutic Melatonin is a therapeutic chemically synthesized form of the pineal indole melatonin with antioxidant properties. The pineal synthesis and secretion of melatonin, a serotonin-derived neurohormone, is dependent on beta-adrenergic receptor function. Melatonin is involved in numerous biological functions including circadian rhythm, sleep, the stress response, aging, and immunity. Melatonin is a hormone involved in sleep regulatory activity, and a tryptophan-derived neurotransmitter, which inhibits the synthesis and secretion of other neurotransmitters such as dopamine and GABA. Melatonin is synthesized from serotonin intermediate in the pineal gland and the retina where the enzyme 5-hydroxyindole-O-methyltransferase, that catalyzes the last step of synthesis, is found. This hormone binds to and activates melatonin receptors and is involved in regulating the sleep and wake cycles. In addition, melatonin possesses antioxidative and immunoregulatory properties via regulating other neurotransmitters. Melatonin is a biogenic amine that is found in animals, plants and microbes. Aaron B. Lerner of Yale University is credited for naming the hormone and for defining its chemical structure in 1958. In mammals, melatonin is produced by the pineal gland. The pineal gland is small endocrine gland, about the size of a rice grain and shaped like a pine cone (hence the name), that is l... Melatonin is a biogenic amine that is found in animals, plants and microbes. Aaron B. Lerner of Yale University is credited for naming the hormone and for defining its chemical structure in 1958. In mammals, melatonin is produced by the pineal gland. The pineal gland is small endocrine gland, about the size of a rice grain and shaped like a pine cone (hence the name), that is located in the center of the brain (rostro-dorsal to the superior colliculus) but outside the blood-brain barrier. The secretion of melatonin increases in darkness and decreases during exposure to light, thereby regulating the circadian rhythms of several biological functions, including the sleep-wake cycle. In particular, melatonin regulates the sleep-wake cycle by chemically causing drowsiness and. lowering the body temperature. Melatonin is also implicated in the regulation of mood,learning and memory, immune activity, dreaming, fertility and reproduction. Melatonin is also an effective antioxidant. Most of the actions of melatonin are mediated through the binding and activation of melatonin receptors. Individuals with autism spectrum disorders(ASD) may have lower than normal levels of melatonin. A 2008 study found that unaffected parents of individuals with ASD also have lower melatonin levels, and that the deficits. were associated with low activity of the ASMT gene, which encodes the last enzyme of melatonin synthesis. Reduced melatonin production has also been proposed as a likely factor in the significantly higher cancer rates in night workers. Melatonin, also known chemically as N-acetyl-5-methoxytryptamine, is a naturally occurring compound found in animals, plants and microbes. In animals, circulating levels of the hormone melatonin vary in a daily cycle, thereby allowing the entrainment of the circadian rhythms of several biological functions. A member of the class of acetamides that is acetamide in which one of the hydrogens attached to the nitrogen atom is replaced by a 2-(5-methoxy-1H-indol-3-yl)ethyl group. It is a hormone secreted by the pineal gland in humans. Melatonin. CAS Common Chemistry. CAS, a division of the American Chemical Society, n.d. https://commonchemistry.cas.org/detail?cas_rn=73-31-4 (retrieved 2024-07-01) (CAS RN: 73-31-4). Licensed under the Attribution-Noncommercial 4.0 International License (CC BY-NC 4.0). Melatonin is a hormone made by the pineal gland that can activates melatonin receptor. Melatonin plays a role in sleep and possesses important antioxidative and anti-inflammatory properties[1][2][3]. Melatonin is a novel selective ATF-6 inhibitor and induces human hepatoma cell apoptosis through COX-2 downregulation[4]. Melatonin attenuates palmitic acid-induced (HY-N0830) mouse granulosa cells apoptosis via endoplasmic reticulum stress[5]. Melatonin is a hormone made by the pineal gland that can activates melatonin receptor. Melatonin plays a role in sleep and possesses important antioxidative and anti-inflammatory properties[1][2][3]. Melatonin is a novel selective ATF-6 inhibitor and induces human hepatoma cell apoptosis through COX-2 downregulation[4]. Melatonin attenuates palmitic acid-induced (HY-N0830) mouse granulosa cells apoptosis via endoplasmic reticulum stress[5].

   

Aminoglutethimide

3-Ethyl-3-(p-aminophenyl)-2,6-dioxopiperidine

C13H16N2O2 (232.1212)


An aromatase inhibitor that produces a state of medical adrenalectomy by blocking the production of adrenal steroids. It also blocks the conversion of androgens to estrogens. Aminoglutethimide has been used in the treatment of advanced breast and prostate cancer. It was formerly used for its weak anticonvulsant properties. (From Martindale, The Extra Pharmacopoeia, 30th ed, p454) CONFIDENCE standard compound; INTERNAL_ID 1173; DATASET 20200303_ENTACT_RP_MIX508; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 3385; ORIGINAL_PRECURSOR_SCAN_NO 3383 CONFIDENCE standard compound; INTERNAL_ID 1173; DATASET 20200303_ENTACT_RP_MIX508; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 7127; ORIGINAL_PRECURSOR_SCAN_NO 7125 CONFIDENCE standard compound; INTERNAL_ID 1173; DATASET 20200303_ENTACT_RP_MIX508; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 7145; ORIGINAL_PRECURSOR_SCAN_NO 7141 CONFIDENCE standard compound; INTERNAL_ID 1173; DATASET 20200303_ENTACT_RP_MIX508; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 3404; ORIGINAL_PRECURSOR_SCAN_NO 3402 CONFIDENCE standard compound; INTERNAL_ID 1173; DATASET 20200303_ENTACT_RP_MIX508; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 3400; ORIGINAL_PRECURSOR_SCAN_NO 3398 CONFIDENCE standard compound; INTERNAL_ID 1173; DATASET 20200303_ENTACT_RP_MIX508; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 7086; ORIGINAL_PRECURSOR_SCAN_NO 7084 CONFIDENCE standard compound; INTERNAL_ID 1173; DATASET 20200303_ENTACT_RP_MIX508; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 7154; ORIGINAL_PRECURSOR_SCAN_NO 7153 CONFIDENCE standard compound; INTERNAL_ID 1173; DATASET 20200303_ENTACT_RP_MIX508; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 3387; ORIGINAL_PRECURSOR_SCAN_NO 3385 CONFIDENCE standard compound; INTERNAL_ID 1173; DATASET 20200303_ENTACT_RP_MIX508; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 3391; ORIGINAL_PRECURSOR_SCAN_NO 3387 CONFIDENCE standard compound; INTERNAL_ID 1173; DATASET 20200303_ENTACT_RP_MIX508; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 7094; ORIGINAL_PRECURSOR_SCAN_NO 7091 CONFIDENCE standard compound; INTERNAL_ID 1173; DATASET 20200303_ENTACT_RP_MIX508; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 3376; ORIGINAL_PRECURSOR_SCAN_NO 3375 CONFIDENCE standard compound; INTERNAL_ID 1173; DATASET 20200303_ENTACT_RP_MIX508; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 7142; ORIGINAL_PRECURSOR_SCAN_NO 7138 L - Antineoplastic and immunomodulating agents > L02 - Endocrine therapy > L02B - Hormone antagonists and related agents > L02BG - Aromatase inhibitors D006730 - Hormones, Hormone Substitutes, and Hormone Antagonists > D006727 - Hormone Antagonists > D065088 - Steroid Synthesis Inhibitors D006730 - Hormones, Hormone Substitutes, and Hormone Antagonists > D006727 - Hormone Antagonists > D004965 - Estrogen Antagonists C274 - Antineoplastic Agent > C2189 - Signal Transduction Inhibitor > C129824 - Antineoplastic Protein Inhibitor D004791 - Enzyme Inhibitors > D065088 - Steroid Synthesis Inhibitors > D047072 - Aromatase Inhibitors C274 - Antineoplastic Agent > C129818 - Antineoplastic Hormonal/Endocrine Agent > C481 - Antiestrogen C274 - Antineoplastic Agent > C163758 - Targeted Therapy Agent > C1740 - Aromatase Inhibitor C147908 - Hormone Therapy Agent > C547 - Hormone Antagonist > C2355 - Anti-Adrenal C471 - Enzyme Inhibitor > C129825 - Antineoplastic Enzyme Inhibitor D000970 - Antineoplastic Agents

   

L-Acetopine

5-carbamimidamido-2-[(carboxymethyl)amino]pentanoic acid

C8H16N4O4 (232.1171)


L-Acetopine is found in fats and oils. L-Acetopine is isolated from calluses of soybean plant and coHon (Gossypium hirsutum). Isolated from calluses of soybean plant and coHon (Gossypium hirsutum). L-Acetopine is found in fats and oils and pulses.

   

(2E)-2-[[(Z)-3-Phenylbut-2-enyl]hydrazinylidene]propanoic acid

(2E)-2-[[(Z)-3-Phenylbut-2-enyl]hydrazinylidene]propanoic acid

C13H16N2O2 (232.1212)


   

1,1-Diphenylhexatriene

(1-phenylhexa-1,3,5-trien-1-yl)benzene

C18H16 (232.1252)


   

1,6-Diphenyl-1,3,5-hexatriene

(6-phenylhexa-1,3,5-trien-1-yl)benzene

C18H16 (232.1252)


   

N-[2-(5-Methoxy-3H-indol-3-yl)ethyl]acetamide

N-[2-(5-Methoxy-3H-indol-3-yl)ethyl]acetamide

C13H16N2O2 (232.1212)


   

Ethyl L-tryptophanate

Tryptophan ethyl ester, alpha-14C-labeled CPD (DL)-isomer

C13H16N2O2 (232.1212)


   

Mofebutazone

4-butyl-3-hydroxy-1-phenyl-4,5-dihydro-1H-pyrazol-5-one

C13H16N2O2 (232.1212)


M - Musculo-skeletal system > M02 - Topical products for joint and muscular pain > M02A - Topical products for joint and muscular pain > M02AA - Antiinflammatory preparations, non-steroids for topical use M - Musculo-skeletal system > M01 - Antiinflammatory and antirheumatic products > M01A - Antiinflammatory and antirheumatic products, non-steroids > M01AA - Butylpyrazolidines C78272 - Agent Affecting Nervous System > C241 - Analgesic Agent > C2198 - Nonnarcotic Analgesic D018373 - Peripheral Nervous System Agents > D018689 - Sensory System Agents D002491 - Central Nervous System Agents > D000700 - Analgesics D000893 - Anti-Inflammatory Agents D018501 - Antirheumatic Agents

   

Pirmagrel

6-{imidazo[1,5-a]pyridin-5-yl}hexanoic acid

C13H16N2O2 (232.1212)


   

1,2-dibutyrin

1-(Butanoyloxy)-3-hydroxypropan-2-yl butanoic acid

C11H20O5 (232.1311)


1,2-dibutyrin, also known as alpha,beta-dibutyrine or (2-butanoyloxy-3-hydroxypropyl) butanoate, is a member of the class of compounds known as 1,2-diacylglycerols. 1,2-diacylglycerols are diacylglycerols containing a glycerol acylated at positions 1 and 2. 1,2-dibutyrin is soluble (in water) and a very weakly acidic compound (based on its pKa). 1,2-dibutyrin can be found in a number of food items such as swede, french plantain, roman camomile, and millet, which makes 1,2-dibutyrin a potential biomarker for the consumption of these food products.

   

N-acetylcytisine

N-acetylcytisine

C13H16N2O2 (232.1212)


relative retention time with respect to 9-anthracene Carboxylic Acid is 0.452 relative retention time with respect to 9-anthracene Carboxylic Acid is 0.447

   

5-Methoxy-1-methylspiro[indoline-3,3-pyrrolidin]-2-one

5-Methoxy-1-methylspiro[indoline-3,3-pyrrolidin]-2-one

C13H16N2O2 (232.1212)


   

6-Chloromethyl-1,8-dimethoxy-2-methyl-2,6-octadiene

6-Chloromethyl-1,8-dimethoxy-2-methyl-2,6-octadiene

C12H21ClO2 (232.123)


   

6-Chloromethyl-3,8-dimethoxy-2-methyl-1,6-octadiene

6-Chloromethyl-3,8-dimethoxy-2-methyl-1,6-octadiene

C12H21ClO2 (232.123)


   

Jioglutin E

Jioglutin E

C11H20O5 (232.1311)


   

Melatonin

N-[2-(5-Methoxy-1H-indol-3-yl)ethyl]acetamide

C13H16N2O2 (232.1212)


N - Nervous system > N05 - Psycholeptics > N05C - Hypnotics and sedatives > N05CH - Melatonin receptor agonists D002491 - Central Nervous System Agents > D002492 - Central Nervous System Depressants D006730 - Hormones, Hormone Substitutes, and Hormone Antagonists > D006728 - Hormones COVID info from clinicaltrial, clinicaltrials, clinical trial, clinical trials C147908 - Hormone Therapy Agent > C548 - Therapeutic Hormone D020011 - Protective Agents > D000975 - Antioxidants C26170 - Protective Agent > C275 - Antioxidant Corona-virus Coronavirus SARS-CoV-2 COVID-19 SARS-CoV COVID19 SARS2 SARS ORIGINAL_PRECURSOR_SCAN_NO 3385; CONFIDENCE standard compound; INTERNAL_ID 961; DATASET 20200303_ENTACT_RP_MIX508; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 3387 CONFIDENCE standard compound; INTERNAL_ID 961; DATASET 20200303_ENTACT_RP_MIX508; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 3387; ORIGINAL_PRECURSOR_SCAN_NO 3385 CONFIDENCE standard compound; INTERNAL_ID 961; DATASET 20200303_ENTACT_RP_MIX508; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 3400; ORIGINAL_PRECURSOR_SCAN_NO 3398 CONFIDENCE standard compound; INTERNAL_ID 961; DATASET 20200303_ENTACT_RP_MIX508; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 3376; ORIGINAL_PRECURSOR_SCAN_NO 3375 CONFIDENCE standard compound; INTERNAL_ID 961; DATASET 20200303_ENTACT_RP_MIX502; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 3184; ORIGINAL_PRECURSOR_SCAN_NO 3183 CONFIDENCE standard compound; INTERNAL_ID 961; DATASET 20200303_ENTACT_RP_MIX508; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 3391; ORIGINAL_PRECURSOR_SCAN_NO 3387 CONFIDENCE standard compound; INTERNAL_ID 961; DATASET 20200303_ENTACT_RP_MIX502; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 3198; ORIGINAL_PRECURSOR_SCAN_NO 3196 CONFIDENCE standard compound; INTERNAL_ID 961; DATASET 20200303_ENTACT_RP_MIX508; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 7086; ORIGINAL_PRECURSOR_SCAN_NO 7084 CONFIDENCE standard compound; INTERNAL_ID 961; DATASET 20200303_ENTACT_RP_MIX502; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 7064; ORIGINAL_PRECURSOR_SCAN_NO 7062 CONFIDENCE standard compound; INTERNAL_ID 961; DATASET 20200303_ENTACT_RP_MIX502; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 7062; ORIGINAL_PRECURSOR_SCAN_NO 7059 CONFIDENCE standard compound; INTERNAL_ID 961; DATASET 20200303_ENTACT_RP_MIX502; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 7093; ORIGINAL_PRECURSOR_SCAN_NO 7090 CONFIDENCE standard compound; INTERNAL_ID 961; DATASET 20200303_ENTACT_RP_MIX502; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 7098; ORIGINAL_PRECURSOR_SCAN_NO 7096 CONFIDENCE standard compound; INTERNAL_ID 961; DATASET 20200303_ENTACT_RP_MIX502; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 7084; ORIGINAL_PRECURSOR_SCAN_NO 7082 relative retention time with respect to 9-anthracene Carboxylic Acid is 0.685 relative retention time with respect to 9-anthracene Carboxylic Acid is 0.686 relative retention time with respect to 9-anthracene Carboxylic Acid is 0.679 relative retention time with respect to 9-anthracene Carboxylic Acid is 0.682 Melatonin is a hormone made by the pineal gland that can activates melatonin receptor. Melatonin plays a role in sleep and possesses important antioxidative and anti-inflammatory properties[1][2][3]. Melatonin is a novel selective ATF-6 inhibitor and induces human hepatoma cell apoptosis through COX-2 downregulation[4]. Melatonin attenuates palmitic acid-induced (HY-N0830) mouse granulosa cells apoptosis via endoplasmic reticulum stress[5]. Melatonin is a hormone made by the pineal gland that can activates melatonin receptor. Melatonin plays a role in sleep and possesses important antioxidative and anti-inflammatory properties[1][2][3]. Melatonin is a novel selective ATF-6 inhibitor and induces human hepatoma cell apoptosis through COX-2 downregulation[4]. Melatonin attenuates palmitic acid-induced (HY-N0830) mouse granulosa cells apoptosis via endoplasmic reticulum stress[5].

   

Maybridge4_003734

Maybridge4_003734

C12H16N4O (232.1324)


   

n-acetyl-o-methylserotonin

n-acetyl-o-methylserotonin

C13H16N2O2 (232.1212)


   
   

methyl (4E)-6,7,9-trihydroxydec-4-enoate

methyl (4E)-6,7,9-trihydroxydec-4-enoate

C11H20O5 (232.1311)


   

3-hydroxy-3-methyl-adipic acid diethyl ester|3-Hydroxy-3-methyl-adipinsaeure-diaethylester|3-Hydroxy-3-methylglutarsaeurediethylester

3-hydroxy-3-methyl-adipic acid diethyl ester|3-Hydroxy-3-methyl-adipinsaeure-diaethylester|3-Hydroxy-3-methylglutarsaeurediethylester

C11H20O5 (232.1311)


   
   

(3S*,4R*,5S*)-5-(1,3-dihydroxy-2-methylbutyl)-4,5-dihydro-4-hydroxy-3,5-dimethylfuran-2(3H)-one|xylariolide C

(3S*,4R*,5S*)-5-(1,3-dihydroxy-2-methylbutyl)-4,5-dihydro-4-hydroxy-3,5-dimethylfuran-2(3H)-one|xylariolide C

C11H20O5 (232.1311)


   

L-Tryptophan, N-methyl-, methyl ester

L-Tryptophan, N-methyl-, methyl ester

C13H16N2O2 (232.1212)


   

SCHEMBL13902795

SCHEMBL13902795

C13H16N2O2 (232.1212)


   

(3R*,4S*,5S*)-4,5-dihydro-5-(1,2-dihydroxy-2-methylbutyl)-4-hydroxy-3,5-dimethylfuran-2(3H)-one|xylariolide B

(3R*,4S*,5S*)-4,5-dihydro-5-(1,2-dihydroxy-2-methylbutyl)-4-hydroxy-3,5-dimethylfuran-2(3H)-one|xylariolide B

C11H20O5 (232.1311)


   

ethyl tryptophanate

ethyl tryptophanate

C13H16N2O2 (232.1212)


   

N-dimethyl-l-tryptophan

N-dimethyl-l-tryptophan

C13H16N2O2 (232.1212)


   

aminoglutethimide

Aminoglutethimide (Cytadren)

C13H16N2O2 (232.1212)


L - Antineoplastic and immunomodulating agents > L02 - Endocrine therapy > L02B - Hormone antagonists and related agents > L02BG - Aromatase inhibitors D006730 - Hormones, Hormone Substitutes, and Hormone Antagonists > D006727 - Hormone Antagonists > D065088 - Steroid Synthesis Inhibitors D006730 - Hormones, Hormone Substitutes, and Hormone Antagonists > D006727 - Hormone Antagonists > D004965 - Estrogen Antagonists C274 - Antineoplastic Agent > C2189 - Signal Transduction Inhibitor > C129824 - Antineoplastic Protein Inhibitor D004791 - Enzyme Inhibitors > D065088 - Steroid Synthesis Inhibitors > D047072 - Aromatase Inhibitors C274 - Antineoplastic Agent > C129818 - Antineoplastic Hormonal/Endocrine Agent > C481 - Antiestrogen C274 - Antineoplastic Agent > C163758 - Targeted Therapy Agent > C1740 - Aromatase Inhibitor C147908 - Hormone Therapy Agent > C547 - Hormone Antagonist > C2355 - Anti-Adrenal C471 - Enzyme Inhibitor > C129825 - Antineoplastic Enzyme Inhibitor D000970 - Antineoplastic Agents

   

2-hexyl-3-hydroxypentanedioic acid

NCGC00380116-01!2-hexyl-3-hydroxypentanedioic acid

C11H20O5 (232.1311)


   

3-Dimethylaminoacetyl-5-methoxyindole

3-Dimethylaminoacetyl-5-methoxyindole

C13H16N2O2 (232.1212)


Origin: Plant; SubCategory_DNP: Alkaloids derived from tryptophan, Simple tryptamine alkaloids, Indole alkaloids

   

Tryptophan ethyl ester

Tryptophan ethyl ester

C13H16N2O2 (232.1212)


   
   

L-Acetopine

5-carbamimidamido-2-[(carboxymethyl)amino]pentanoic acid

C8H16N4O4 (232.1171)


   

ETHYL 5-[3-(DIMETHYLAMINO)PROP-1-YNYL]NICOTINATE

ETHYL 5-[3-(DIMETHYLAMINO)PROP-1-YNYL]NICOTINATE

C13H16N2O2 (232.1212)


   

(R)-1-Methylmephenytoin

(R)-1-Methylmephenytoin

C13H16N2O2 (232.1212)


   

ethyl (3r,5s)-6-hydroxy-3,5-o-iso-propylidene-3,5-dihydroxyhexanoate

ethyl (3r,5s)-6-hydroxy-3,5-o-iso-propylidene-3,5-dihydroxyhexanoate

C11H20O5 (232.1311)


   

4,6(1H,5H)-Pyrimidinedione,5-ethyldihydro-5-(4-methylphenyl)-

4,6(1H,5H)-Pyrimidinedione,5-ethyldihydro-5-(4-methylphenyl)-

C13H16N2O2 (232.1212)


   

1,6-DIPHENYL-1,3,5-HEXATRIENE

1,6-DIPHENYL-1,3,5-HEXATRIENE

C18H16 (232.1252)


D019995 - Laboratory Chemicals > D007202 - Indicators and Reagents > D049408 - Luminescent Agents D004396 - Coloring Agents > D005456 - Fluorescent Dyes

   

1-(2-METHYLPHENOXY)-2-PROPANOL

1-(2-METHYLPHENOXY)-2-PROPANOL

C12H16N4O (232.1324)


   

1-ETHYL-2-METHYL-1H-BENZOIMIDAZOLE-5-CARBOXYLIC ACID ETHYL ESTER

1-ETHYL-2-METHYL-1H-BENZOIMIDAZOLE-5-CARBOXYLIC ACID ETHYL ESTER

C13H16N2O2 (232.1212)


   

(1H-IMIDAZOL-4-YL)-P-TOLYL-METHANONE

(1H-IMIDAZOL-4-YL)-P-TOLYL-METHANONE

C13H16N2O2 (232.1212)


   

N-(3-(3-Hydroxyprop-1-ynyl)pyridin-2-yl)pivalamide

N-(3-(3-Hydroxyprop-1-ynyl)pyridin-2-yl)pivalamide

C13H16N2O2 (232.1212)


   

7-N-Boc-Aminoindole

7-N-Boc-Aminoindole

C13H16N2O2 (232.1212)


   

METHYL 1-(TERT-BUTYL)-1H-BENZO[D]IMIDAZOLE-5-CARBOXYLATE

METHYL 1-(TERT-BUTYL)-1H-BENZO[D]IMIDAZOLE-5-CARBOXYLATE

C13H16N2O2 (232.1212)


   

Methyl 1-tert-butyl-1H-benzo[d]imidazole-6-carboxylate

Methyl 1-tert-butyl-1H-benzo[d]imidazole-6-carboxylate

C13H16N2O2 (232.1212)


   

N-CBZ-2,5-DIAZABICYCLO[2.2.1]HEPTANE

N-CBZ-2,5-DIAZABICYCLO[2.2.1]HEPTANE

C13H16N2O2 (232.1212)


   

(-)-MENTHOXYACETYL CHLORIDE

(-)-MENTHOXYACETYL CHLORIDE

C12H21ClO2 (232.123)


   

DIETHYL 3-METHYLCYCLOHEX-1-ENYLPHOSPHONATE

DIETHYL 3-METHYLCYCLOHEX-1-ENYLPHOSPHONATE

C11H21O3P (232.1228)


   

(S)-aminoglutethimide

(-)-Aminoglutethimide

C13H16N2O2 (232.1212)


   

2-(2-morpholin-4-ylethoxy)benzonitrile

2-(2-morpholin-4-ylethoxy)benzonitrile

C13H16N2O2 (232.1212)


   

PIPERIDINO(2-PIPERIDINYL)METHANONE HYDROCHLORIDE

PIPERIDINO(2-PIPERIDINYL)METHANONE HYDROCHLORIDE

C11H21ClN2O (232.1342)


   

(S,S)-(+)-PSEUDOEPHEDRINEGLYCINAMIDE

(S,S)-(+)-PSEUDOEPHEDRINEGLYCINAMIDE

C13H16N2O2 (232.1212)


   

1-Boc-4-aminoindole

1-Boc-4-aminoindole

C13H16N2O2 (232.1212)


   

Naphthalene,2-(2-phenylethyl)-

Naphthalene,2-(2-phenylethyl)-

C18H16 (232.1252)


   

tert-butyl-(3-ethynylphenoxy)-dimethylsilane

tert-butyl-(3-ethynylphenoxy)-dimethylsilane

C14H20OSi (232.1283)


   

4-Formylphenylboronic acid pinacol cyclic ester

4-Formylphenylboronic acid pinacol cyclic ester

C13H17BO3 (232.1271)


   

3-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)benzaldehyde

3-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)benzaldehyde

C13H17BO3 (232.1271)


   

TERT-BUTYL 5-METHYL-1H-BENZO[D]IMIDAZOLE-1-CARBOXYLATE

TERT-BUTYL 5-METHYL-1H-BENZO[D]IMIDAZOLE-1-CARBOXYLATE

C13H16N2O2 (232.1212)


   

4-benzoylpiperazine-1-carboxamidine

4-benzoylpiperazine-1-carboxamidine

C12H16N4O (232.1324)


   

Methyl 4-methyl-2-propyl-1H-benzimidazole-6-carboxylate

Methyl 4-methyl-2-propyl-1H-benzimidazole-6-carboxylate

C13H16N2O2 (232.1212)


   

N-(1-CARBAMOYL-CYCLOPENTYL)-BENZAMIDE

N-(1-CARBAMOYL-CYCLOPENTYL)-BENZAMIDE

C13H16N2O2 (232.1212)


   

(CHLOROMETHYL)VINYLBENZENE

(CHLOROMETHYL)VINYLBENZENE

C13H16N2O2 (232.1212)


   

1-(3-PIPERIDINYLCARBONYL)PIPERIDINEMONOHYDROCHLORIDE

1-(3-PIPERIDINYLCARBONYL)PIPERIDINEMONOHYDROCHLORIDE

C11H21ClN2O (232.1342)


   

D-Aminoglutethimide

(R)-aminoglutethimide

C13H16N2O2 (232.1212)


   

1-BENZYL-3(R)-ETHYL-PIPERAZINE-2,5-DIONE

1-BENZYL-3(R)-ETHYL-PIPERAZINE-2,5-DIONE

C13H16N2O2 (232.1212)


   

1-BENZYL-3-ETHYL-PIPERAZINE-2,5-DIONE

1-BENZYL-3-ETHYL-PIPERAZINE-2,5-DIONE

C13H16N2O2 (232.1212)


   

TERT-BUTYL 1H-INDOL-5-YLCARBAMATE

TERT-BUTYL 1H-INDOL-5-YLCARBAMATE

C13H16N2O2 (232.1212)


   

tert-butyl 4-cyanobenzylcarbamate

tert-butyl 4-cyanobenzylcarbamate

C13H16N2O2 (232.1212)


   

5-(5-Amino-3-(tert-butyl)-1H-pyrazol-1-yl)pyridin-2(1H)-one

5-(5-Amino-3-(tert-butyl)-1H-pyrazol-1-yl)pyridin-2(1H)-one

C12H16N4O (232.1324)


   

tert-Butyl 1H-indol-4-ylcarbamate

tert-Butyl 1H-indol-4-ylcarbamate

C13H16N2O2 (232.1212)


   

N-Allyl-N,N-dimethyl-2-propen-1-aminium chloride - acrylamide (1: 1:1)

N-Allyl-N,N-dimethyl-2-propen-1-aminium chloride - acrylamide (1: 1:1)

C11H21ClN2O (232.1342)


   

piperidine, 1-(4-piperidinylcarbonyl)-, hydrochloride

piperidine, 1-(4-piperidinylcarbonyl)-, hydrochloride

C11H21ClN2O (232.1342)


   

tert-butyl N-[(S)-cyano(phenyl)methyl]carbamate

tert-butyl N-[(S)-cyano(phenyl)methyl]carbamate

C13H16N2O2 (232.1212)


   

(6,7-DIMETHOXY-1,2,3,4-TETRAHYDRO-ISOQUINOLIN-1-YL)-ACETONITRILE

(6,7-DIMETHOXY-1,2,3,4-TETRAHYDRO-ISOQUINOLIN-1-YL)-ACETONITRILE

C13H16N2O2 (232.1212)


   

(S)-N-Cbz-Valinenitrile

(S)-N-Cbz-Valinenitrile

C13H16N2O2 (232.1212)


   

Trimethylsilylketene Ethyl Trimethylsilyl Acetal (mixture of isomers)

Trimethylsilylketene Ethyl Trimethylsilyl Acetal (mixture of isomers)

C10H24O2Si2 (232.1315)


   

2-(4-Methoxyphenyl)-2,5-diazaspiro[3.4]octan-1-one

2-(4-Methoxyphenyl)-2,5-diazaspiro[3.4]octan-1-one

C13H16N2O2 (232.1212)


   

2-Ethyl-8-methyl-2,8-diazaspiro[4.5]decan-1-one hydrochloride (1: 1)

2-Ethyl-8-methyl-2,8-diazaspiro[4.5]decan-1-one hydrochloride (1: 1)

C11H21ClN2O (232.1342)


   

3-(4-Ethoxyphenyl)-1,4-dimethyl-1H-pyrazol-5-ol

3-(4-Ethoxyphenyl)-1,4-dimethyl-1H-pyrazol-5-ol

C13H16N2O2 (232.1212)


   

phenyl-7-amino-5-azaspiro[2.4]heptane-5-carboxylate

phenyl-7-amino-5-azaspiro[2.4]heptane-5-carboxylate

C13H16N2O2 (232.1212)


   

4-(2-morpholin-4-ylethoxy)benzonitrile

4-(2-morpholin-4-ylethoxy)benzonitrile

C13H16N2O2 (232.1212)


   

4,6(1H,5H)-Pyrimidinedione,dihydro-5-phenyl-5-propyl-

4,6(1H,5H)-Pyrimidinedione,dihydro-5-phenyl-5-propyl-

C13H16N2O2 (232.1212)


   

2-tert-butyl-1-methyl-5-nitroindole

2-tert-butyl-1-methyl-5-nitroindole

C13H16N2O2 (232.1212)


   

ethyl 2-amino-3-(1H-indol-2-yl)propanoate

ethyl 2-amino-3-(1H-indol-2-yl)propanoate

C13H16N2O2 (232.1212)


   

(S)-1-BENZYL-3-ETHYLPIPERAZINE-2,5-DIONE

(S)-1-BENZYL-3-ETHYLPIPERAZINE-2,5-DIONE

C13H16N2O2 (232.1212)


   

METHYLTRIGLYCOLMETHACRYLATE

METHYLTRIGLYCOLMETHACRYLATE

C11H20O5 (232.1311)


   

3-CBZ-3,6-DIAZABICYCLO[3.2.0]HEPTANE

3-CBZ-3,6-DIAZABICYCLO[3.2.0]HEPTANE

C13H16N2O2 (232.1212)


   

3-(2-morpholin-4-ylethoxy)benzonitrile

3-(2-morpholin-4-ylethoxy)benzonitrile

C13H16N2O2 (232.1212)


   

11-prop-2-enylidene-5,6-dihydrodibenzo[2,1-b:2,1-f][7]annulene

11-prop-2-enylidene-5,6-dihydrodibenzo[2,1-b:2,1-f][7]annulene

C18H16 (232.1252)


   

Pirmagrel

Pirmagrel

C13H16N2O2 (232.1212)


C78275 - Agent Affecting Blood or Body Fluid > C1327 - Antiplatelet Agent D007155 - Immunologic Factors > D007166 - Immunosuppressive Agents C308 - Immunotherapeutic Agent > C574 - Immunosuppressant D004791 - Enzyme Inhibitors

   

(R)-3-CHLORO-2-METHYLPROPIONYLCHLORIDE

(R)-3-CHLORO-2-METHYLPROPIONYLCHLORIDE

C11H20O5 (232.1311)


   

N-[3-(3-DIMETHYLAMINO-1-OXO-2-PROPENYL)PHENYL]ACETAMIDE

N-[3-(3-DIMETHYLAMINO-1-OXO-2-PROPENYL)PHENYL]ACETAMIDE

C13H16N2O2 (232.1212)


   

α-Methyl-D,L-tryptophan Methyl Ester

α-Methyl-D,L-tryptophan Methyl Ester

C13H16N2O2 (232.1212)


   

1-Boc-6-Aminoindole

1-Boc-6-Aminoindole

C13H16N2O2 (232.1212)


   
   

4-(2-Amino-4-cyano-phenyl)-butyric acid ethyl ester

4-(2-Amino-4-cyano-phenyl)-butyric acid ethyl ester

C13H16N2O2 (232.1212)


   

1-(4,6-Dimethylpyrimidin-2-yl)-4-ethyl-3-methyl-1H-pyrazol-5-ol

1-(4,6-Dimethylpyrimidin-2-yl)-4-ethyl-3-methyl-1H-pyrazol-5-ol

C12H16N4O (232.1324)


   

4-(Cyclohexanecarbonyl)phenylboronic acid

4-(Cyclohexanecarbonyl)phenylboronic acid

C13H17BO3 (232.1271)


   

2-(1,4-diazepan-1-yl)-5-methyl[1,3]oxazolo[4,5-b]pyridine(SALTDATA: FREE)

2-(1,4-diazepan-1-yl)-5-methyl[1,3]oxazolo[4,5-b]pyridine(SALTDATA: FREE)

C12H16N4O (232.1324)


   

ETHYL 5,6-DIMETHYL-1H-BENZIMIDAZOL-1-YL)ACETATE

ETHYL 5,6-DIMETHYL-1H-BENZIMIDAZOL-1-YL)ACETATE

C13H16N2O2 (232.1212)


   
   

2-Formylphenylboronic acid pinacol ester

2-Formylphenylboronic acid pinacol ester

C13H17BO3 (232.1271)


   

9-Nitro(2H9)anthracene

9-Nitro(2H9)anthracene

C14D9NO2 (232.1198)


   

N-cyanoethyl-N-acetoxyethyl aniline

N-cyanoethyl-N-acetoxyethyl aniline

C13H16N2O2 (232.1212)


   

1-Boc-5-aminoindole

1-Boc-5-aminoindole

C13H16N2O2 (232.1212)


   

1-piperidin-4-yl-4H-3,1-benzoxazin-2-one

1-piperidin-4-yl-4H-3,1-benzoxazin-2-one

C13H16N2O2 (232.1212)


   

Tasipimidine

Tasipimidine

C13H16N2O2 (232.1212)


C78272 - Agent Affecting Nervous System > C29747 - Adrenergic Agent > C87053 - Adrenergic Agonist

   

1,2-dibutyrin

[(2S)-2-butanoyloxy-3-hydroxypropyl] butanoate

C11H20O5 (232.1311)


A dibutyrin resulting from the condensation the secondary hydroxy group and one of the primary hydroxy groups of glycerol with butyric acid.

   

DIBUTYRIN

Butanoic acid, diester with 1,2,3-propanetriol

C11H20O5 (232.1311)


A diglyceride resulting from the formal condensation of any two of the hydroxy groups of glycerol with the carboxy groups of two molecules of butanoic acid (either R1 = H and R2 = butanoyl, or R1 = butanoyl and R2 = H). A closed class.

   

2-(2-Cyclohexylidenehydrazinyl)benzoic acid

2-(2-Cyclohexylidenehydrazinyl)benzoic acid

C13H16N2O2 (232.1212)


   

6-Amino-3-methyl-4-(2-methylpropyl)-2,4-dihydropyrano[2,3-c]pyrazole-5-carbonitrile

6-Amino-3-methyl-4-(2-methylpropyl)-2,4-dihydropyrano[2,3-c]pyrazole-5-carbonitrile

C12H16N4O (232.1324)


   

Ethyl L-tryptophanate

Ethyl L-tryptophanate

C13H16N2O2 (232.1212)


   

2-(dimethylamino)-1-(5-methoxy-1H-indol-3-yl)ethanone

2-(dimethylamino)-1-(5-methoxy-1H-indol-3-yl)ethanone

C13H16N2O2 (232.1212)


   

Mofebutazone

Mofebutazone

C13H16N2O2 (232.1212)


M - Musculo-skeletal system > M02 - Topical products for joint and muscular pain > M02A - Topical products for joint and muscular pain > M02AA - Antiinflammatory preparations, non-steroids for topical use M - Musculo-skeletal system > M01 - Antiinflammatory and antirheumatic products > M01A - Antiinflammatory and antirheumatic products, non-steroids > M01AA - Butylpyrazolidines C78272 - Agent Affecting Nervous System > C241 - Analgesic Agent > C2198 - Nonnarcotic Analgesic D018373 - Peripheral Nervous System Agents > D018689 - Sensory System Agents D002491 - Central Nervous System Agents > D000700 - Analgesics D000893 - Anti-Inflammatory Agents D018501 - Antirheumatic Agents

   

5-[(4-Hydroxyphenyl)methyl]-3-imino-4,4-dimethylpyrrolidin-2-one

5-[(4-Hydroxyphenyl)methyl]-3-imino-4,4-dimethylpyrrolidin-2-one

C13H16N2O2 (232.1212)


   

(3R)-N-acetyl-3-hydroxy-L-arginine

(3R)-N-acetyl-3-hydroxy-L-arginine

C8H16N4O4 (232.1171)


   

(2S,3R)-2-acetamido-5-(diaminomethylideneamino)-3-hydroxypentanoic acid

(2S,3R)-2-acetamido-5-(diaminomethylideneamino)-3-hydroxypentanoic acid

C8H16N4O4 (232.1171)


   

1,1-Diphenyl-1,3,5-hexatriene

1,1-Diphenyl-1,3,5-hexatriene

C18H16 (232.1252)


   

(2E)-2-[[(E)-3-phenylbut-2-enyl]hydrazinylidene]propanoic acid

(2E)-2-[[(E)-3-phenylbut-2-enyl]hydrazinylidene]propanoic acid

C13H16N2O2 (232.1212)


   

N-(4-methylphenyl)carbamic acid (cyclopentylideneamino) ester

N-(4-methylphenyl)carbamic acid (cyclopentylideneamino) ester

C13H16N2O2 (232.1212)


   

2-amino-3-hydroxy-N-(2,2,4,4-tetramethylthietan-3-yl)propanamide

2-amino-3-hydroxy-N-(2,2,4,4-tetramethylthietan-3-yl)propanamide

C10H20N2O2S (232.1245)


   

Trimethylsilyl 4-(2,2-dimethylhydrazino)-4-oxobutanoate

Trimethylsilyl 4-(2,2-dimethylhydrazino)-4-oxobutanoate

C9H20N2O3Si (232.1243)


   

Alanyl-beta-alanine, TMS derivative

Alanyl-beta-alanine, TMS derivative

C9H20N2O3Si (232.1243)


   

4-Methoxy-4-phenyl-3-trimethylsilyl-1,2-butadiene

4-Methoxy-4-phenyl-3-trimethylsilyl-1,2-butadiene

C14H20OSi (232.1283)


   

2-Hexyl-3-hydroxypentanedioic acid

2-Hexyl-3-hydroxypentanedioic acid

C11H20O5 (232.1311)


   

(1-Acetyloxy-3-hydroxypropan-2-yl) hexanoate

(1-Acetyloxy-3-hydroxypropan-2-yl) hexanoate

C11H20O5 (232.1311)


   

(1-Hydroxy-3-propanoyloxypropan-2-yl) pentanoate

(1-Hydroxy-3-propanoyloxypropan-2-yl) pentanoate

C11H20O5 (232.1311)


   

[(2S)-2-butanoyloxy-3-hydroxypropyl] butanoate

[(2S)-2-butanoyloxy-3-hydroxypropyl] butanoate

C11H20O5 (232.1311)


   

1,3-dibutyrin

1,3-dibutyrin

C11H20O5 (232.1311)


A dibutyrin resulting from the condensation of both of the primary hydroxy groups of glycerol with butyric acid.

   

(1r,9s)-11-acetyl-7,11-diazatricyclo[7.3.1.0²,⁷]trideca-2,4-dien-6-one

(1r,9s)-11-acetyl-7,11-diazatricyclo[7.3.1.0²,⁷]trideca-2,4-dien-6-one

C13H16N2O2 (232.1212)


   

n-[(2s)-1-hydroxy-3-(1h-indol-3-yl)propan-2-yl]ethanimidic acid

n-[(2s)-1-hydroxy-3-(1h-indol-3-yl)propan-2-yl]ethanimidic acid

C13H16N2O2 (232.1212)


   

(2s)-2-(dimethylamino)-3-(1h-indol-3-yl)propanoic acid

(2s)-2-(dimethylamino)-3-(1h-indol-3-yl)propanoic acid

C13H16N2O2 (232.1212)


   

5-(1,3-dihydroxy-2-methylbutyl)-4-hydroxy-3,5-dimethyloxolan-2-one

5-(1,3-dihydroxy-2-methylbutyl)-4-hydroxy-3,5-dimethyloxolan-2-one

C11H20O5 (232.1311)


   

(3r)-5-methoxy-1'-methylspiro[indole-3,3'-pyrrolidin]-2-ol

(3r)-5-methoxy-1'-methylspiro[indole-3,3'-pyrrolidin]-2-ol

C13H16N2O2 (232.1212)


   

(1s,3r,4ar,5r,7s,7as)-1,3-dimethoxy-7-methyl-hexahydro-1h-cyclopenta[c]pyran-5,7-diol

(1s,3r,4ar,5r,7s,7as)-1,3-dimethoxy-7-methyl-hexahydro-1h-cyclopenta[c]pyran-5,7-diol

C11H20O5 (232.1311)


   

2-(dimethylamino)-3-(1h-indol-3-yl)propanoic acid

2-(dimethylamino)-3-(1h-indol-3-yl)propanoic acid

C13H16N2O2 (232.1212)


   

1,6-diethyl (3r)-3-hydroxy-3-methylhexanedioate

1,6-diethyl (3r)-3-hydroxy-3-methylhexanedioate

C11H20O5 (232.1311)


   

methyl (4e,6s,7r,9s)-6,7,9-trihydroxydec-4-enoate

methyl (4e,6s,7r,9s)-6,7,9-trihydroxydec-4-enoate

C11H20O5 (232.1311)


   

(3s,4r,5r)-5-(1,2-dihydroxy-2-methylbutyl)-4-hydroxy-3,5-dimethyloxolan-2-one

(3s,4r,5r)-5-(1,2-dihydroxy-2-methylbutyl)-4-hydroxy-3,5-dimethyloxolan-2-one

C11H20O5 (232.1311)


   

n-[2-(5-methoxy-1h-indol-3-yl)ethyl]ethanimidic acid

n-[2-(5-methoxy-1h-indol-3-yl)ethyl]ethanimidic acid

C13H16N2O2 (232.1212)


   

6-(chloromethyl)-3,8-dimethoxy-2-methylocta-1,6-diene

6-(chloromethyl)-3,8-dimethoxy-2-methylocta-1,6-diene

C12H21ClO2 (232.123)


   

methyl 6,7,9-trihydroxydec-4-enoate

methyl 6,7,9-trihydroxydec-4-enoate

C11H20O5 (232.1311)


   

5-methoxy-1'-methylspiro[indole-3,3'-pyrrolidin]-2-ol

5-methoxy-1'-methylspiro[indole-3,3'-pyrrolidin]-2-ol

C13H16N2O2 (232.1212)


   

5-(1,2-dihydroxy-2-methylbutyl)-4-hydroxy-3,5-dimethyloxolan-2-one

5-(1,2-dihydroxy-2-methylbutyl)-4-hydroxy-3,5-dimethyloxolan-2-one

C11H20O5 (232.1311)


   

1,6-diethyl 3-hydroxy-3-methylhexanedioate

1,6-diethyl 3-hydroxy-3-methylhexanedioate

C11H20O5 (232.1311)


   

(3r,6z)-6-(chloromethyl)-3,8-dimethoxy-2-methylocta-1,6-diene

(3r,6z)-6-(chloromethyl)-3,8-dimethoxy-2-methylocta-1,6-diene

C12H21ClO2 (232.123)


   

methyl (2s)-3-(1h-indol-3-yl)-2-(methylamino)propanoate

methyl (2s)-3-(1h-indol-3-yl)-2-(methylamino)propanoate

C13H16N2O2 (232.1212)


   

methyl 3-(1h-indol-3-yl)-2-(methylamino)propanoate

methyl 3-(1h-indol-3-yl)-2-(methylamino)propanoate

C13H16N2O2 (232.1212)


   

(3s,6's)-5',6'-dimethylspiro[indole-3,2'-[1,5]oxazinan]-2-ol

(3s,6's)-5',6'-dimethylspiro[indole-3,2'-[1,5]oxazinan]-2-ol

C13H16N2O2 (232.1212)


   

(2z,6e)-3-(chloromethyl)-1,8-dimethoxy-7-methylocta-2,6-diene

(2z,6e)-3-(chloromethyl)-1,8-dimethoxy-7-methylocta-2,6-diene

C12H21ClO2 (232.123)


   

11-acetyl-7,11-diazatricyclo[7.3.1.0²,⁷]trideca-2,4-dien-6-one

11-acetyl-7,11-diazatricyclo[7.3.1.0²,⁷]trideca-2,4-dien-6-one

C13H16N2O2 (232.1212)


   

5',6'-dimethylspiro[indole-3,2'-[1,5]oxazinan]-2-ol

5',6'-dimethylspiro[indole-3,2'-[1,5]oxazinan]-2-ol

C13H16N2O2 (232.1212)


   

1',2-dimethyl-1,2-dihydrospiro[3,1-benzoxazine-4,3'-pyrrolidin]-2'-one

1',2-dimethyl-1,2-dihydrospiro[3,1-benzoxazine-4,3'-pyrrolidin]-2'-one

C13H16N2O2 (232.1212)


   

(2s,4r)-1',2-dimethyl-1,2-dihydrospiro[3,1-benzoxazine-4,3'-pyrrolidin]-2'-one

(2s,4r)-1',2-dimethyl-1,2-dihydrospiro[3,1-benzoxazine-4,3'-pyrrolidin]-2'-one

C13H16N2O2 (232.1212)


   

n-[1-hydroxy-3-(1h-indol-3-yl)propan-2-yl]ethanimidic acid

n-[1-hydroxy-3-(1h-indol-3-yl)propan-2-yl]ethanimidic acid

C13H16N2O2 (232.1212)


   
   

(1s,9r)-11-acetyl-7,11-diazatricyclo[7.3.1.0²,⁷]trideca-2,4-dien-6-one

(1s,9r)-11-acetyl-7,11-diazatricyclo[7.3.1.0²,⁷]trideca-2,4-dien-6-one

C13H16N2O2 (232.1212)


   

6-(chloromethyl)-1,8-dimethoxy-2-methylocta-2,6-diene

6-(chloromethyl)-1,8-dimethoxy-2-methylocta-2,6-diene

C12H21ClO2 (232.123)


   

(3s,4r,5s)-5-(1,3-dihydroxy-2-methylbutyl)-4-hydroxy-3,5-dimethyloxolan-2-one

(3s,4r,5s)-5-(1,3-dihydroxy-2-methylbutyl)-4-hydroxy-3,5-dimethyloxolan-2-one

C11H20O5 (232.1311)


   

(1s,3r,7s)-1,3-dimethoxy-7-methyl-hexahydro-1h-cyclopenta[c]pyran-5,7-diol

(1s,3r,7s)-1,3-dimethoxy-7-methyl-hexahydro-1h-cyclopenta[c]pyran-5,7-diol

C11H20O5 (232.1311)